Peptide therapy claims on TikTok: separating hype from evidence

What did @realestatezola actually say?

This video is less a claims video and more a first-person documentation of someone injecting peptides for the first time. The creator says they "finally" got the bacteriostatic solution needed to reconstitute their peptides, filled multiple vials, and injected two of them at a dose they describe as "0.5, which is 10 units of each." They were anxious before the first injection, then surprised it barely hurt. That is essentially the full content.

There are no explicit health claims here. No one says these peptides will heal an injury, boost growth hormone, or extend lifespan. The video is procedural. But procedural videos carry their own risks: they normalize self-injection of unregulated compounds without showing what informed oversight looks like. That absence matters, and we will get into it.

Does the science back this up?

On the narrow mechanics shown, yes. Subcutaneous injections are genuinely low-pain when done correctly, and the anxiety-before-injection experience the creator describes is well-documented in nursing and patient-reported literature. But the science on the peptides themselves is far more complicated than this video implies by omission.

BPC-157, TB-500, and the other peptides common in this category have plausible mechanisms in animal models. BPC-157, for instance, has shown angiogenic and anti-inflammatory effects in rodent studies (Chang et al., 2011, Journal of Physiology-Paris). GHK-Cu has shown wound-healing properties in vitro (Pickart et al., 2015, Journal of Aging Research). But human randomized controlled trial data is sparse to nonexistent for most of these compounds used in the self-optimization context. The gap between rat data and human clinical outcomes is not a small one. It is the entire ballgame.

The reconstitution process the creator describes, using bacteriostatic water to dissolve lyophilized peptide powder, is standard practice. Getting that wrong introduces contamination risk, which is a real concern with unregulated compounded peptides.

What did they get wrong (or right)?

The creator got the anxiety part exactly right. Needle anxiety is real, common, and not a sign of weakness. Studies on insulin self-injection populations consistently show that anticipatory anxiety exceeds actual pain experience (Zambanini et al., 1999, Diabetic Medicine). Credit where it is due.

What is missing is harder to see but more important. The creator does not say what peptides are in those vials. They do not say where they sourced them. They do not mention a prescribing clinician or compounding pharmacy. Peptides marketed online as "research chemicals" are not subject to FDA manufacturing oversight, and contamination and mislabeling are documented problems in this supply chain (Cohen et al., 2022, JAMA Internal Medicine covers analogous issues in the supplement space).

The dose framing is also worth flagging. Saying "0.5, which is 10 units" is technically correct syringe math for a U-100 insulin syringe, but without knowing the reconstitution ratio used, that number means nothing in terms of actual peptide dose. The video gives no information about concentration, so viewers watching as a tutorial cannot actually replicate a safe dose from this content.

What should you actually know?

If you are curious about peptide therapy, here is what this video does not tell you. First, the regulatory status of most of these compounds matters. The FDA has placed several peptides, including BPC-157 and TB-500, on a list of substances that cannot be compounded for patient use under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act as of recent guidance. That legal landscape is still shifting, but sourcing these compounds without a licensed provider creates real legal and safety exposure.

Second, self-injection without medical supervision means no baseline labs, no monitoring for adverse effects, and no accountability if something goes wrong. Peptides that affect growth hormone secretion, like CJC-1295 or ipamorelin, can alter IGF-1 levels. Unchecked IGF-1 elevation is associated with increased cancer risk in observational data (Renehan et al., 2004, Lancet). That is not a reason to panic, but it is a reason to have a clinician run bloodwork.

Third, purity of unverified peptides is genuinely unknown. A 2021 analysis of peptides purchased from online research chemical vendors found significant variation in purity and concentration (Brennan et al., 2021, Drug Testing and Analysis). What is in the vial may not match the label.

Bottom line

This video is not misinformation exactly. It is a low-information personal experience post that makes self-injection of unverified compounds look routine and uncomplicated. The creator's subjective experience is valid. The framing that this is a normal, easy thing to do without clinical oversight is the part that deserves scrutiny. Peptide therapy used through a licensed telehealth provider with proper sourcing, lab monitoring, and medical supervision is a different category of activity than what this video depicts.